Cited by 451Pregnancy and preeclampsia studiesClinical practice guidelines implementationBirth, Development, and Health

Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy

Open access
McCowan, Lesley M., Figueras, Francesc, Anderson, Ngaire H.·2018·American Journal of Obstetrics and Gynecology

Abstract

Small for gestational age is usually defined as an infant with a birthweight <10th centile for a population or customized standard. Fetal growth restriction refers to a fetus that has failed to reach its biological growth potential because of placental dysfunction. Small-for-gestational-age babies make up 28-45% of nonanomalous stillbirths, and have a higher chance of neurodevelopmental delay, childhood and adult obesity, and metabolic disease. The majority of small-for-gestational-age babies are not recognized before birth. Improved identification, accompanied by surveillance and timely delivery, is associated with reduction in small-for-gestational-age stillbirths. Internationally and regionally, detection of small for gestational age and management of fetal growth problems vary considerably. The aim of this review is to: summarize areas of consensus and controversy between recently published national guidelines on small for gestational age or fetal growth restriction; highlight any recent evidence that should be incorporated into existing guidelines; and identify future research priorities in this field. A search of MEDLINE, Google, and the International Guideline Library identified 6 national guidelines on management of pregnancies complicated by fetal growth restriction/small for gestational age published from 2010 onwards. There is general consensus between guidelines (at least 4 of 6 guidelines in agreement) in early pregnancy risk selection, and use of low-dose aspirin for women with major risk factors for placental insufficiency. All highlight the importance of smoking cessation to prevent small for gestational age. While there is consensus in recommending fundal height measurement in the third trimester, 3 specify the use of a customized growth chart, while 2 recommend McDonald rule. Routine third-trimester scanning is not recommended for small-for-gestational-age screening, while women with major risk factors should have serial scanning in the third trimester. Umbilical artery Doppler studies in suspected small-for-gestational-age pregnancies are universally advised, however there is inconsistency in the recommended frequency for growth scans after diagnosis of small for gestational age/fetal growth restriction (2-4 weekly). In late-onset fetal growth restriction (≥32 weeks) general consensus is to use cerebral Doppler studies to influence surveillance and/or delivery timing. Fetal surveillance methods (most recommend cardiotocography) and recommended timing of delivery vary. There is universal agreement on the use of corticosteroids before birth at <34 weeks, and general consensus on the use of magnesium sulfate for neuroprotection in early-onset fetal growth restriction (<32 weeks). Most guidelines advise using cardiotocography surveillance to plan delivery in fetal growth restriction <32 weeks. The recommended gestation at delivery for fetal growth restriction with absent and reversed end-diastolic velocity varies from 32 to ≥34 weeks and 30 to ≥34 weeks, respectively. Overall, where there is high-quality evidence from randomized controlled trials and meta-analyses, eg, use of umbilical artery Doppler and corticosteroids for delivery <34 weeks, there is a high degree of consistency between national small-for-gestational-age guidelines. This review discusses areas where there is potential for convergence between small-for-gestational-age guidelines based on existing randomized controlled trials of management of small-for-gestational-age pregnancies, and areas of controversy. Research priorities include assessing the utility of late third-trimester scanning to prevent major morbidity and mortality and to investigate the optimum timing of delivery in fetuses with late-onset fetal growth restriction and abnormal Doppler parameters. Prospective studies are needed to compare new international population ultrasound standards with those in current use.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ajog.2017.12.004

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Of fetuses diagnosed with fetal growth restriction, approximately 18%-22% will be constitutionally small but healthy at birth with a normal outcome.

    “Of fetuses diagnosed with FGR, approximately 18%e22% will be constitutionally small but healthy at birth with a normal outcome.24”

    From Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction (2020) · cites this paper as [24]

    The Introduction says 18–22% of babies classified as small for gestational age (SGA) are constitutionally small but healthy. The Expert Reviews section says reclassified babies have perinatal mortality similar to normally grown babies. The figure applies to SGA infants, not fetuses diagnosed with FGR, and similar mortality does not establish a normal outcome in every respect. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Protocols for umbilical artery Doppler in FGR surveillance vary from weekly to a 2-to 4-week interval.

    “Protocols vary from weekly umbilical artery Doppler to a 2-to 4-week interval.24,108”

    From Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction (2020) · cites this paper as [24]

    Table 4 (Conclusions; page not supplied) shows that recommended umbilical artery Doppler intervals vary, including weekly and every two weeks, depending on the guideline and Doppler findings. The Results section gives a 2–4-week interval for ongoing growth scans, not umbilical artery Doppler, so the claimed four-week Doppler interval is unsupported. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • A review of national guidelines from 6 countries reveals broad consensus that fetal growth restriction is defined as an ultrasonographic estimated fetal weight below the 10th percentile for gestational age.

    “A review of national guidelines for the diagnostic criteria for FGR from 6 countries (United States, United Kingdom, France, Ireland, Canada, and New Zealand) reveals a broad consensus on this definition of FGR.24”
  • National guidelines from 4 countries recommend cesarean delivery when FGR is complicated by AEDV/REDV of the umbilical artery.

    “National guidelines from 4 countries recommend cesarean delivery when FGR is complicated by AEDV/REDV of the umbilical artery.24”
  • A prospective observational study suggests that rapid progression of Doppler abnormalities in FGR, if it occurs, is typically noted within the first 2 weeks after diagnosis.

    “A prospective observational study of the progression of Doppler abnormalities in FGR suggests that rapid progression, if it is going to occur, is typically noted within the first 2 weeks after diagnosis.24,108”

    From Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction (2020) · cites this paper as [24]

    The Results discuss surveillance after FGR diagnosis, and the Conclusions table lists Doppler monitoring intervals. Neither reports a prospective observational study finding that rapid Doppler deterioration typically appears within the first two weeks after diagnosis. Searches for that study and the two-week progression claim found no supporting passage in our copy. (LLM, conf=0.73)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. [16]16. Sharma D, Farahbakhsh N, Shastri S, Sharma P. Intrauterine growth restrictionepart 2. J Matern Fetal Neonatal Med 2016;29: 4037-48.
  2. [21]21. Wright J, Morse K, Kody S. Audit of fundal height measurement plotted on customized growth charts. MIDIRS Midwifery Digest 2006;16:341-5.
  3. [26]26. Boers KE, Vijgen SM, Bijlenga D, et al. In- duction versus expectant monitoring for intra- uterine growth restriction at term: randomized equivalence trial (DIGITAT). BMJ 2010;341: c7087.
  4. [30]30. Lausman A, Kingdom J. Intrauterine growth restriction: screening, diagnosis and manage- ment. SOGC clinical practice guideline no. 295. J Obstet Gynaecol Can 2013;35:741-8.
  5. [90]90. Westerway SC, Davison A, Cowell S. Ultra- sonic fetal measurements: new Australian stan- dards for the new millennium. Aust N Z J Obstet Gynaecol 2000;40:297-302.

Cited by

Sorted by citations

Authors
McCowan, L. M., Figueras, F., & Anderson, N. H.
Affiliations
  • University of Auckland (NZ)
  • Hospital Sant Joan de Déu Barcelona (ES)
Corresponding author
McCowan, Lesley M.
Venue
American Journal of Obstetrics and Gynecology
Publisher
Elsevier BV
Published
2018-02
Volume
218
Issue
2
Pages
S855-S868
ISSN
0002-9378 (ISSN-L)
OpenAlex
W2793911400
Cited by
451
References
93
Citations by year
2026: 37 · 2025: 49 · 2024: 34 · 2023: 55 · 2022: 93 · 2021: 78 · 2020: 53 · 2019: 42 · 2018: 8 · 2016: 1 · 2013: 1
FWCI
50.96
Type
journal article
Language
en
Open access
Locations
  • American Journal of Obstetrics and Gynecology (publishedVersion)
  • PubMed (publishedVersion)
  • ResearchSpace (University of Auckland) (submittedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
Keywords
fetal growth restriction, small for gestational age, placental insufficiency, low-dose aspirin, smoking cessation, fundal height measurement, umbilical artery Doppler, cardiotocography, corticosteroids, magnesium sulfate, delivery timing, stillbirth prevention
MeSH terms
Aspirin, Canada, Female, Fetal Growth Retardation, France, United Kingdom, Humans, Infant, Newborn, Infant, Small for Gestational Age, Ireland, New Zealand, Placental Insufficiency, Platelet Aggregation Inhibitors, Pregnancy, Prenatal Care, Umbilical Arteries, United States, Biomarkers, Ultrasonography, Prenatal, Smoking Cessation, Practice Guidelines as Topic, Risk Assessment, Ultrasonography, Doppler, Evidence-Based Medicine, Consensus, Growth Charts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review